The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells

By sjmartinez • February 19, 2024

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2024 Feb;100:104900. doi: 10.1016/j.ebiom.2023.104900. Epub 2023 Dec 12. PMID: 38092579.

Tags: Cardiology/Epi, Cedars Sinai DoM, Harbor UCLA, Progenitor cell therapy, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, Regenerative medicine, right ventricle, Short- and long-term safety, Veterans Administration

Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Right Ventricular Outflow Tract, Part 2

Miyazaki Y, Park YM, Rimmer M, Miyazaki K, Yamagami S, Izawa Y, Osai N, Hanna P, Fishbein MC, Shivkumar K, Mori S. Understanding Cardiac Anatomy[...]

PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study

Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin[...]

Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review

Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]